LONDON, United Kingdom — A new COVID-19 variant, dubbed “razor blade throat” COVID, has emerged, prompting concerns as infection rates rise in various regions. This variant, known as NB.1.8.1, or “Nimbus,” is being linked to notably painful sore throats reported by medical professionals in the UK, India, and other locations.

As countries monitor this development, other typical symptoms associated with COVID-19, such as fever, cough, shortness of breath, and alterations in taste or smell, remain the same across variants. Despite the alarming nickname, experts indicate that there is no immediate reason for heightened alarm regarding Nimbus.

The World Health Organization (WHO) noted that late last month saw a noticeable uptick in COVID-19 cases, particularly in the eastern Mediterranean, Southeast Asia, and western Pacific regions. By mid-May, Nimbus constituted almost 11% of the sequenced COVID-19 samples worldwide.

In the United States, airport screenings have detected the Nimbus variant among travelers arriving from affected regions, with cases identified in areas including California, Washington, Virginia, and New York. Public health officials are remaining vigilant as they track the variant’s spread.

Current trends suggest that Nimbus does not lead to more severe illness than its predecessors. The WHO has reported increases in COVID-19 cases and hospitalizations in some western Pacific nations but asserts that there is no evidence indicating that this variant causes more serious disease.

Vaccinations continue to be a key component of protection against COVID-19, including the Nimbus variant. The WHO has classified Nimbus as a “variant under monitoring,” conveying that the global public health risk is still considered low. Experts emphasize that existing vaccines are expected to remain effective against this variant.

Despite ongoing debates surrounding vaccine recommendations, such as recent statements from Health Secretary Robert F. Kennedy Jr. suggesting that COVID-19 vaccinations are no longer necessary for healthy children and pregnant women, many public health officials have expressed skepticism about these conclusions.

In the face of ongoing COVID-19 challenges, the emergence of Nimbus underscores the importance of continuing surveillance, vaccination efforts, and public awareness to mitigate the impact of the pandemic. As new variants arise, maintaining a clear focus on public health guidance will be essential in navigating the evolving landscape of COVID-19.